Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Diabetologia ; 55(5): 1535-43, 2012 May.
Article in English | MEDLINE | ID: mdl-22311417

ABSTRACT

AIMS/HYPOTHESIS: Increased oxygen consumption results in kidney tissue hypoxia, which is proposed to contribute to the development of diabetic nephropathy. Oxidative stress causes increased oxygen consumption in type 1 diabetic kidneys, partly mediated by uncoupling protein-2 (UCP-2)-induced mitochondrial uncoupling. The present study investigates the role of UCP-2 and oxidative stress in mitochondrial oxygen consumption and kidney function in db/db mice as a model of type 2 diabetes. METHODS: Mitochondrial oxygen consumption, glomerular filtration rate and proteinuria were investigated in db/db mice and corresponding controls with and without coenzyme Q10 (CoQ10) treatment. RESULTS: Untreated db/db mice displayed mitochondrial uncoupling, manifested as glutamate-stimulated oxygen consumption (2.7 ± 0.1 vs 0.2 ± 0.1 pmol O(2) s(-1) [mg protein](-1)), glomerular hyperfiltration (502 ± 26 vs 385 ± 3 µl/min), increased proteinuria (21 ± 2 vs 14 ± 1, µg/24 h), mitochondrial fragmentation (fragmentation score 2.4 ± 0.3 vs 0.7 ± 0.1) and size (1.6 ± 0.1 vs 1 ± 0.0 µm) compared with untreated controls. All alterations were prevented or reduced by CoQ10 treatment. Mitochondrial uncoupling was partly inhibited by the UCP inhibitor GDP (-1.1 ± 0.1 pmol O(2) s(-1) [mg protein](-1)). UCP-2 protein levels were similar in untreated control and db/db mice (67 ± 9 vs 67 ± 4 optical density; OD) but were reduced in CoQ10 treated groups (43 ± 2 and 38 ± 7 OD). CONCLUSIONS/INTERPRETATION: db/db mice displayed oxidative stress-mediated activation of UCP-2, which resulted in mitochondrial uncoupling and increased oxygen consumption. CoQ10 prevented altered mitochondrial function and morphology, glomerular hyperfiltration and proteinuria in db/db mice, highlighting the role of mitochondria in the pathogenesis of diabetic nephropathy and the benefits of preventing increased oxidative stress.


Subject(s)
Diabetic Nephropathies/drug therapy , Ion Channels/physiology , Kidney Glomerulus/drug effects , Mitochondria/drug effects , Mitochondrial Proteins/physiology , Proteinuria/drug therapy , Ubiquinone/analogs & derivatives , Vitamins/therapeutic use , Animals , Blood Glucose/drug effects , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/physiopathology , Diabetic Nephropathies/physiopathology , Disease Models, Animal , Glomerular Filtration Rate/drug effects , Glomerular Filtration Rate/physiology , Guanosine Diphosphate/metabolism , Ion Channels/blood , Kidney Glomerulus/physiopathology , Kidney Glomerulus/ultrastructure , Mice , Mitochondria/ultrastructure , Mitochondrial Proteins/blood , Oxidative Stress/drug effects , Oxidative Stress/physiology , Oxygen Consumption/drug effects , Oxygen Consumption/physiology , Proteinuria/physiopathology , Ubiquinone/therapeutic use , Uncoupling Protein 2
SELECTION OF CITATIONS
SEARCH DETAIL
...